Vice President, U.S. Brand Lead, KarXT, Alzheimer's Disease Psychosis

Bristol Myers Squibb is a company dedicated to transforming patients' lives through science. The U.S. Brand Lead for KarXT in Alzheimer's Disease Psychosis is a critical leadership role responsible for ensuring the U.S. launch readiness and commercialization of KarXT, collaborating across various functions to deliver a successful strategy and achieving financial targets.

Responsibilities:

• The US Brand Lead will be responsible for ensuring launch success of KarXT in ADP, if approved by the FDA
• This leader will be responsible for the development of all aspects of the U.S. KarXT ADP commercial strategy
• She or He will be accountable for leading a team of talented professionals with diverse backgrounds, experiences and perspectives to support current and future indications, and managing this team with Inclusion to ensure we are enhancing our competitiveness and driving innovation for the ultimate benefit of patients
• Additionally, working in close partnership with the U.S. Brand Lead for Cobenfy Psychiatry, as well as, key matrix functions such as GCS, Business Insight & Analytics, Medical, Market Access, Sales, and Legal, this leader will ensure a fully aligned and integrated strategy across indications and all matrix functions to deliver a seamless launch to U.S. customers
• The U.S. Brand Lead will have full commercial P&L ownership for the indication and accountability for delivering against all financial and forecast targets